Αρχική Uncategorized Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study Finds

Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study Finds

For patients with the earliest stage of breast cancer, lymph node biopsies do not benefit them or improve outcomes, a study out of Yale shows.DCIS (ductal carcinoma in situ) is breast cancer that has formed in the milk ducts. It is the earliest stage of breast cancer and is typically noninvasive. Roughly 60,000 women are diagnosed with DCIS every year in the United States.This is the first study to show evidence that lymph nodes biopsies are not beneficial to patients with DCIS. These finding should hopefully lead to improved treatment guidelines.“Our study actually showed that there is no benefit of sentinel node biopsy in terms of breast cancer mortality, breast cancer recurrence or invasive breast cancer,” said Shi-Yi Wang, co-author of the study. She’s a health services researcher at Yale School of Public Health in New Haven, Connecticut.Photo: Adobe Stock/michaelheim
The study was published in the Journal of the National Cancer Institute Cancer Spectrum and lead by researchers at Yale.Using the Surveillance, Epidemiology, and End Results-Medicare database, which contains about 12,000 patients, the team identified 1,992 women who received a sentinel lymph node biopsy. They then identified 3,965 women in the database who did not have the biopsy and who had similarities to the patients who had, such as age and tumor characteristics.All the women in the study were 67 years old or older, had been diagnosed with DCIS sometime between 2001 through 2013, and had received breast-conserving surgery.Photo: Adobe Stock/lyosha_nazarenko
Looking at the two groups, the researchers found three key results. First, there was no significant difference between the groups when it came to recurrence and needing a mastectomy. There was also no significant difference between groups when it came to invasive breast cancer cropping up in the same breast later on. Third, both groups had a similar rate of death from breast cancer.Lymph node biopsies experienced a strong uptick in the first part of the century. All lymph node biopsies for patients with DCIS who received breast-conserving surgery rose from around 20% to 44% between 1998 and 2011. This happened in large part because the rate of sentinel lymph node biopsies — which are the ones closest to the original site of the cancer — increased sharply, from around 7% to 39%.Photo: Adobe Stock/7activestudio
“Unnecessary surgery places patients at higher risk for surgical complications and adds to overall healthcare costs,” said Bridig Killelea, co-author of the study and a Yale associate surgery professor.Thankfully, most surgeons have already stopped performing this procedure on patients with DCIS. However, some still do. Hopefully these findings will lead to improved and updated guidelines for all breast cancer surgeons to follow.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...

Nivolumab-Based Combinations Improve Survival in Advanced Esophageal Cancer

June 17, 2021, by NCI Staff An x-ray of the esophagus and upper gastrointestinal tract following a barium swallow test.  Credit: iStock For some people with advanced...

Wales: 4 in 10 with possible cancer symptoms didn’t contact GP

New figures show 42.1% of people surveyed in Wales who experienced possible cancer symptoms in the first wave of the pandemic didn’t contact their...

Survey Shows Oncologists Underestimate How Many Cancer Patients Use Alternative Therapies

Many cancer patients use alternative or complementary therapies in conjunction with their main course of treatment, but a new survey shows that many oncologists...

Ground-breaking trial pilots new tests to detect lung cancer earlier

Credit: Southampton Clinical Trials Unit The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer...